Companies: 10,795·Total market cap: $144.5T
Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc.

RIGLNASDAQHealthcare● Active
$30.08
+$0.15(+0.50%)
Market Cap$556542566
P/E Ratio
52W High$52.24
52W Low$18.14
Overview

Rigel Pharmaceuticals, Inc. (RIGL) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

rigl · stock forecast · 15 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 15 Wall Street analysts in the past 3 months

SellBuy

Buy

15 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
8
Hold
7
Sell
0
Strong Sell
0
Total: 15 · Buy rate: 53.3%

12-Month Price Target

High

$42.00

Consensus

$27.33

-9.1% upside

Low

$2.00

Median: $38 · Last Close: $30.08

The Rigel Pharmaceuticals, Inc. (RIGL) analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month RIGL price target is $27.33, representing -9.1% upside from the current price of $30.08.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $27 (-9.1%)

Consensus Target

$27.33

-9.1% upside

High Target

$42

39.6%

Low Target

$2

-93.4%

Current Price

$30.08

as of today

Based on analyst price targets, the RIGL stock price prediction for the next 12 months ranges from $2 to $42. The consensus RIGL price forecast of $27.33 implies -9.1% upside from the current price of $30.08.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$30.381.00%

1-day model range: $30.17–$30.59. Peak: $30.59 (+1.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$32+7.6%
2028$34+12.1%
2029$35+14.7%
2030$35+16.2%
2031+17.0%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

57%7%36%
8Buy
1Neutral
5Sell
RSI (14)66.5Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · RIGL · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$30.12SELL
MA 10$29.96BUY
MA 20$29.61BUY
MA 50$29.41BUY
MA 100$31.05SELL
MA 200$34.38SELL
Current $RIGL · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$30.06BUY
EMA 10$29.91BUY
EMA 20$29.67BUY
EMA 50$29.85BUY
EMA 100$31.04SELL
EMA 200$31.03SELL
Current $RIGL · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
HC Wainwright & Co.2026-06-02
Maintains
BuyBuy
HC Wainwright & Co.2026-05-27
Maintains
BuyBuy
HC Wainwright & Co.2026-05-22
Maintains
BuyBuy
Citigroup2026-05-13
Maintains
BuyBuy
Citigroup2026-05-07
Maintains
BuyBuy
Jefferies2025-11-05
Upgrade ↑
HoldBuy
Cantor Fitzgerald2025-11-05
Maintains
NeutralNeutral
HC Wainwright & Co.2025-10-08
Maintains
BuyBuy
Cantor Fitzgerald2025-08-06
Maintains
NeutralNeutral
Cantor Fitzgerald2025-05-07
Maintains
NeutralNeutral

Wall Street analysts have recently issued updated ratings on Rigel Pharmaceuticals, Inc. (RIGL) stock. Of the recent 95 rating actions, 4 were upgrades and 9 were downgrades. 15 analysts currently cover RIGL.

Analyst Recommendation Trends

Buy ratings01↑ +1
Hold ratings101
Sell ratings00

RIGL analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$270M

↓ 27.2% YoY

Revenue Next Year

$330M

↑ 22.2% YoY

EPS This Year

$3.15

EPS Next Year

$4.38

↑ 39.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast RIGL EPS of $3.15 for the current fiscal year, based on estimates from 3 analysts. The RIGL revenue forecast is $270M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The RIGL stock forecast is supported by two independent data sources: analyst consensus ratings from 15 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus RIGL price target is $27.33 (-9.1% upside), with an analyst consensus of Buy.

The RIGL short-term stock prediction for tomorrow is $30.38 (+1.00%). The RIGL stock price prediction for 2027 estimates an average of $32. The RIGL stock prediction for 2030 projects a range of $32–$38.

Rigel Pharmaceuticals, Inc. trades on NASDAQ under the ticker RIGL. The RIGL stock outlook for 2027 is broadly positive, supported by a Buy consensus among 53% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

RIGL forecast · 8 questions

According to 15 Wall Street analysts, the average 12-month RIGL price target is $27.33, with a high forecast of $42.00 and a low of $2.00. The median price target is shown in the chart above when available. This implies -9.1% potential upside from the current price of $30.08.

RIGL price targetWhat is RIGL price targetRIGL analyst price targetRIGL 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.